X4 Pharmaceuticals, Inc.

JPMORGAN CHASE & CO

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/12/2025

Shares

165,438

Value ($000)

39

Weight

0.0%

2019 Q4 - 2025 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/12/2025	39	0.0%	165,438	3/31/2025
2024 Q4	2/12/2025	337	0.0%	459,653	12/31/2024
2024 Q3	11/8/2024	51	0.0%	76,476	9/30/2024
2024 Q2	8/12/2024	43	0.0%	74,247	6/30/2024
2024 Q1	5/10/2024	71	0.0%	51,127	3/31/2024
2023 Q4	2/12/2024	67	0.0%	79,805	12/31/2023
2023 Q3	11/14/2023	87	0.0%	79,805	9/30/2023
2023 Q2	8/11/2023	185	0.0%	95,463	6/30/2023
2023 Q1	5/18/2023	545	0.0%	626,047	3/31/2023
2022 Q4	2/13/2023	119	0.0%	119,598	12/31/2022
2021 Q4	2/11/2022	0	0.0%	203	12/31/2021
2021 Q2	8/12/2021	308	0.0%	47,334	6/30/2021
2021 Q1	5/12/2021	396	0.0%	46,025	3/31/2021
2020 Q4	2/19/2021	252	0.0%	39,126	12/31/2020
2020 Q3	11/12/2020	58	0.0%	8,632	9/30/2020
2020 Q2	8/11/2020	155	0.0%	16,700	6/30/2020
2020 Q1	5/12/2020	38	0.0%	3,817	3/31/2020
2019 Q4	2/11/2020	42	0.0%	3,908	12/31/2019